Hypercalcemia of malignancy factor, specifically the fragment 1-16, is a peptide associated with the pathological condition of hypercalcemia, often seen in patients with certain malignancies. This fragment is derived from a larger protein involved in calcium regulation and is known to influence bone metabolism and calcium homeostasis. The presence of this peptide can lead to increased osteoclastic activity, resulting in elevated calcium levels in the bloodstream, which is a common complication in cancer patients. The CAS number 126391-27-3 identifies this specific peptide, indicating its unique chemical structure and properties. Typically, such peptides are characterized by their specific amino acid sequence, which dictates their biological activity and interaction with cellular receptors. In therapeutic contexts, understanding the characteristics of this factor can aid in developing treatments for managing hypercalcemia in malignancy, highlighting the importance of peptide fragments in medical research and clinical applications.

hypercalcemia of malignancy factor*fragment 1-16

126391-27-3: Hypercalcemia of malignancy factor, specifically the fragment 1-16, is a peptide associated with the pathological condition of hypercalcemia, often seen in patients with certain malignancies. This fragment is derived from a larger protein involved in calcium regulation and is known to influence bone metabolism and calcium homeostasis. The presence of this peptide can lead to increased osteoclastic activity, resulting in elevated calcium levels in the bloodstream, which is a common complication in cancer patients. The CAS number 126391-27-3 identifies this specific peptide, indicating its unique chemical structure and properties. Typically, such peptides are characterized by their specific amino acid sequence, which dictates their biological activity and interaction with cellular receptors. In therapeutic contexts, understanding the characteristics of this factor can aid in developing treatments for managing hypercalcemia in malignancy, highlighting the importance of peptide fragments in medical research and clinical applications.

<p>Please enquire for more information about pTH-Related Protein (1-16) (human, mouse, rat) including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

CAS 126391-27-3

hypercalcemia of malignancy factor*fragment 1-16

pTH-Related Protein (1-16) (human, mouse, rat)

Ref: 3D-FP109885